Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8767113 | Revista Clínica Española | 2018 | 9 Pages |
Abstract
Hepatitis C virus infection is a significant public health problem. The introduction of direct-acting antiviral agents, whose efficacy is greater than 90% in all patient groups (including those with cirrhosis), has represented a highly relevant change compared with classical interferon-based therapies. Tolerance for these antiviral agents is significantly better, and the treatment duration is shorter. This review updates the treatment of hepatitis C virus infection with the new direct-acting antiviral agents.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
M.J. Vivancos, A. Moreno, C. Quereda,